The Current Update of Vaccines for SARS-CoV-2
Hoang Duc Ha 1, Nguyen Minh Duc 2 3 * , Pham Minh Thong 4 5
More Detail
1 Department of Radiology, Haiphong University of Medicine and Pharmacy, Hai Phong City, VIETNAM2 Department of Radiology, Pham Ngoc Thach University of Medicine, Ho Chi Minh City, VIETNAM3 Department of Radiology, Children’s Hospital 2, Ho Chi Minh City, VIETNAM4 Department of Radiology, Hanoi Medical University, Ha Noi, VIETNAM5 Department of Radiology, Bach Mai Hospital, Ha Noi, VIETNAM* Corresponding Author


Late 2019 witnessed the appearance of coronavirus disease 2019 (COVID-19) outbreak triggered by a new coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 spread across China from Wuhan and has been circulated to a broader variety of countries. Seeing that COVID-19 has caused tremendous human casualties posing a global danger, an awareness of the current situation and the strategies to curtail the spread of the virus are desperately required. As the most natural way to preserve public wellbeing, preventive and therapeutic vaccinations must have essential roles. Large organizations and companies have started implementing SARS-CoV-2 preventive vaccinations. Hence, in this study, we aimed to update the vaccine evolution for SARS-CoV-2.


This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Perspective Article

ELECTRON J GEN MED, Volume 17, Issue 5, October 2020, Article No: em248

Publication date: 02 May 2020

Article Views: 7856

Article Downloads: 3639

Open Access Disclosures References How to cite this article